SPY—
QQQ—
DIA—
NVDA—
AAPL—
TSLA—
MSFT—
BTC-USD—
15-min delayed
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Apnimed, Inc. Common Stock

APMD XNAS
$16.09 -1.16 (-6.70%) ▼ 15-min delayed
Open
$17.08
High
$17.73
Low
$15.95
Volume
248.6K
Market Cap
$669.84M

About Apnimed, Inc. Common Stock

Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).

Sector: PHARMACEUTICAL PREPARATIONS Website →

Related Market News

No specific coverage for APMD yet. Check out our latest market news or earnings calendar.

Get APMD Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Apnimed, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.